Brain & Cognition research
Adamax
An experimental Semax-related compound with very little direct published evidence of its own.
This profile separates what has been directly studied from what is only proposed, inherited, or unverified.
- Last reviewed
- Last reviewed August 26, 2026
- Author
- Peptides Made Clear Editorial Team
- Reading time
- 2 min read
Illuminated neural network across cortical regions of a human brain, rendered in cyan and teal light on a deep navy scientific backdrop.
Start here
Adamax in one minute
What is it?
An experimental Semax-related compound with very little direct published evidence of its own.
Why are researchers interested?
Suppliers and community write-ups propose BDNF or TrkB-related neurotrophic signaling and improved stability or tissue penetration. These are proposals, not demonstrated Adamax findings.
Inferred from a related peptideHow much evidence exists?
No verified studies for this exact compound were found in the current source library.
Claimed but unverifiedWhat is the biggest unknown?
- · Does Adamax reach the brain in humans at all?
- · Does the adamantyl modification change activity, stability, or neither?
- · Is any marketed material actually the described molecule?
Body systems
What could Adamax affect in the body?
This section describes research questions—not guaranteed effects or personal outcomes.
Brain and nervous system
Proposed only — not demonstrated- What are researchers studying?
- Adamax is discussed in relation to cognitive and neurological research, but direct Adamax-specific studies have not been verified.
- What kind of evidence supports this?
- Proposed mechanisms are primarily inferred from Semax research and from supplier descriptions.
- What remains unknown?
- Whether Adamax produces any measurable neurological effect in humans, animals, or cells has not been demonstrated in a verified source.
Pathways referenced in the literature: BDNF signaling, Cholinergic signaling, HPA-axis regulation.
Plain English
The simplest way to understand it
The simplest way to understand Adamax: it is presented as a modified relative of Semax, but most scientific claims made about Adamax come from Semax—not Adamax itself.
No verified studies for this exact compound were found in the current source library.
Inferred from a related peptideSemax has a published research record, largely from Russian clinical and preclinical work. Those results describe Semax. They do not demonstrate that Adamax behaves the same way.
Claimed but unverified- · Claimed to be more potent than Semax
- · Claimed to last longer than Semax
- · Claimed to cross the blood-brain barrier more readily
Evidence
What has actually been studied?
Evidence levels are assigned per claim, and only when verified citations exist for this exact peptide.
Neural signaling, focus, and mood
Claim scored: Adamax · Brain & Cognition
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Why this level? No verified studies for this exact peptide were found in the current source library, so the bar stays unlit rather than borrowing a level from a related compound.
Related-compound evidence
Semax evidence — not Adamax evidence
Semax studies are shown here for context. Semax has a published research record and is registered for clinical use in Russia.
They do not demonstrate that Adamax produces the same effects, reaches the same tissues, or carries the same safety profile.
Level 1 · Laboratory
Observed in cells, tissue, or computational models only.
Level 2 · Animal
Studied in animal models; results often do not transfer to people.
Level 3 · Early Human
Small, early-stage, or uncontrolled studies in humans.
Level 4 · Controlled Human
Randomized or otherwise controlled human trials exist.
Level 5 · Established
Reviewed by a regulator or established in clinical practice for a specific use.
Mechanism
How might it work?
Structural relationship to Semax
ProposedAdamax is described as Semax with an adamantane-type modification attached.
Neurotrophic signaling (BDNF / TrkB)
ProposedSome sources say Adamax raises BDNF signaling. That has been reported for Semax, not for Adamax.
Stability and tissue penetration
UnknownThe modification is proposed to make the molecule more stable or better able to reach brain tissue.
Human research
What do we know from human research?
No verified Adamax-specific human trial was found in the current source library. No results timeline is shown, because there are no verified human outcomes to place on one.
The study library is empty for this exact peptide. Related-compound sources are shown in their own labeled box above and are never counted here.
Research timeline
Adamax Results & Research Timeline
What published studies measured, when they measured it, and what remains unknown.
No verified results timeline exists for Adamax
We did not find a verified exact-peptide study that tracked outcomes over time. Showing weekly or monthly changes here would create an expectation that has not been established by research.
No verified Adamax-specific study has tracked cognitive, neurological, physical, or other outcomes over time. Claims about weekly or monthly changes are therefore not displayed.
What we would need to build a timeline
- A verified exact-peptide study
- A defined study population or model
- Measured timepoints
- Clearly reported outcomes
- An identifiable formulation
- A citable primary source
Why do other websites show a Adamax timeline?
Some timelines are assembled from community discussions, vendor descriptions, or assumptions based on Semax. Those sources do not establish a verified Adamax results timeline.
Studied administration
How has Adamax been studied?
This section reports administration details found in published research or official regulatory sources. It is not a personal-use protocol.
Research record, not a protocol
Nothing in this section is a dose, schedule, or instruction. Each record describes one study exactly as its source reported it.No verified Adamax-specific human protocol
No verified human study establishing a dose, route, frequency, timing, or duration for Adamax was found in the current source library.
Formulation
Not established
Human dose
Not established
Route
Not established
Frequency
Not established
Duration
Not established
Pharmacokinetics
Not established
Why this information is unavailable
Numbers commonly shown online appear to come from community practices, supplier descriptions, or assumptions based on Semax. They must not be presented as an Adamax study protocol.
See Semax research context
Semax has published study protocols. Those protocols apply to Semax and do not establish an Adamax protocol.
Source-gated review
Protocol Evidence
No protocol is published for Adamax
No numeric regimen appears until a primary source supports every number and the regulatory status, rest-period evidence, and medical review are complete.
- Protocol status
- Evidence Review Pending
- Evidence level
- Evidence Review Pending
- Regulatory status
- Evidence Review Pending
- Rest Period / Off-Period
- Review pending
Storage and laboratory handling
Exact stability and storage data have not been verified for this material.
Stability varies by peptide, formulation, and manufacturer, so no shared shelf-life figure is applied here. Reconstitution guidance is intentionally kept out of profiles; the reconstitution calculator remains a separate mathematical tool.
Safety
What is known—and not known—about safety?
Human safety data
No verified human safety study for Adamax was found.
Animal and laboratory data
No verified animal safety study for Adamax was found.
What stays unknown
- · Absorption, distribution, and elimination are unknown
- · Interaction risk is unknown
- · Long-term effects are unknown
- · Purity and identity of supplied material are unverified
An absence of reports is not evidence of safety
No personal safety recommendations are given on this page.Regulatory status
Investigational / unapproved — No regulator has been verified as having reviewed or approved Adamax. Semax registration in some countries applies to Semax, not to Adamax.
Last verified Not recorded. Regulatory status varies by country, formulation, and indication.
Global research activity
Where has this exact peptide been researched?
No verified country-level research activity has been recorded for this exact peptide. Vendor availability, customs status, and online sales are never treated as proof of research.
Research presence does not mean legal sale, approval, safety, or effectiveness.
Context
What makes it different?
Relationship to related molecules
Described by suppliers as an adamantane-modified relative of Semax. The relationship is structural, not evidential.A structural relationship does not transfer evidence. Each compound below is scored on its own verified sources.
- Semax: Named parent compound; most Adamax claims originate in Semax research.
- P-21: Another investigational nootropic peptide frequently discussed alongside Semax-family compounds.
Questions
Frequently asked questions
What is Adamax?
Adamax is an experimental compound described by suppliers as a modified relative of Semax. It has very little direct published research of its own.
Is Adamax the same as Semax?
No. Adamax is described as a structurally modified relative of Semax. A structural relationship does not mean the two behave the same way in the body.
Has Adamax been studied in humans?
No verified Adamax-specific human trial was found in the current source library.
Why is Semax research mentioned on an Adamax page?
Because nearly every claim made about Adamax borrows from Semax research. We show that context separately and label it clearly so it is not mistaken for Adamax evidence.
Does Adamax cross the blood-brain barrier?
This is claimed by suppliers, but no verified study measuring Adamax penetration into the brain was found.
Is Adamax FDA-approved?
No approval or formal regulatory review of Adamax has been verified. It is investigational and unapproved.
What evidence exists for Adamax?
At present, no verified exact-compound studies are in our source library. The evidence bar therefore stays unlit rather than borrowing a level from Semax.
Where can I see the original studies?
Any verified source we hold appears in the study library on this page, grouped by whether it studied Adamax itself or a related compound.
What remains unknown about Adamax?
Almost everything measurable: activity, dose-response, pharmacokinetics, safety, and whether marketed material matches the described molecule.
Honest limits
What this profile cannot tell you
- It cannot predict an individual response.
- Research findings do not automatically establish a personal benefit.
- Animal and laboratory findings do not automatically translate to humans.
- Related-peptide evidence does not prove the exact peptide behaves the same way.
- Regulatory status varies by country and indication.
- This page does not replace medical advice or approved prescribing information.
This profile is provided for educational purposes only and is not medical advice or an instruction for use.